Amitay Weiss governance cluster

Cross-portfolio compensation confirmed at minimum ~$488K/year from 4 of 9+ issuers: Clearmind (~$244K), ParaZero (~$224K), Viewbix (~$12K), Charging Robotics ($9K); Maris-Tech, Jeffs' Brands, SciSparc, and N2OFF amounts not individually disclosed

ParaZero 20-F (FY2025, accession 0001213900-26-034376) compensation table shows Amitay Weiss (Chairman of Board) received: $113,938 salary/fee + $45,000 pension/benefits + $65,244 share-based compensation = $224,183 total. Viewbix 10-K (FY2025) shows $11,584 share grant. Charging Robotics 10-K (FY2025) shows $9,000 director compensation. Clearmind Medicine 20-F (FY2025, year ended Oct 31) shows Chairman management fees $142,053 + share-based $101,458 = $243,511. Minimum confirmed cross-portfolio total: ~$488K from 4 of 9+ issuers.

Weiss received 116,286 restricted shares at no cost from N2OFF/Nexentis on Feb 9, 2026 — post-HFIA window; total holding 129,144 shares

Form 4 (accession 0001493152-26-006192, filed 2026-02-11, period 2026-02-09) at N2OFF Inc. (CIK 0001789192, ticker NITO/NXTS). Transaction code A (award). Security: Restricted Shares of Common Stock. Shares acquired: 116,286. Price per share: $0. Shares held after transaction: 129,144. Weiss relationship: Director.

SciSparc (Weiss chairman) took on $10M convertible note facility from entity that is also Xylo's parent — Xylo separately sold IP to SciSparc for 19.99% of shares; combined dilution risk exceeds 23M shares from initial $2M note at $0.123 conversion price

SciSparc F-3 (accession 0001213900-26-017502, filed 2026-02-17) discloses: On Feb 12, 2026, SciSparc entered an SPA with a 'Notes Investor' who is 'the sole shareholder of Xylo' (Xylo Technologies Ltd., CIK 0001618500). Notes Investor received: (i) $2M convertible note (initial tranche of $10M facility) at 90 cents on the dollar, conversion price $0.123/share = 18,368,679 potential shares; (ii) warrant for 3,651,554 shares; (iii) pre-funded warrant for 1,017,391 shares held by Xylo. Total registered shares: 23,037,624.

Three F-3 shelf registrations at Weiss-chaired issuers filed within 48 hours in February 2026 — SciSparc, Clearmind Medicine, and Jeffs' Brands — all via Toppan Merrill, suggesting coordinated capital market activity

Three separate shelf registrations (F-3) filed within a 2-day window across Weiss-chaired issuers: SciSparc (0001213900-26-017502, Feb 17), Clearmind Medicine (0001213900-26-017379, Feb 17), Jeffs' Brands (0001213900-26-018510, Feb 19). All three used EDGAR agent 0001213900 (Toppan Merrill). Concurrent shelf filings across a chairman's portfolio issuers may indicate coordinated liquidity/exit planning by shared investors or the portfolio itself.

Amitay Weiss Management Ltd. confirmed as Weiss's primary shareholding/consulting vehicle since April 2016; used to hold indirect beneficial positions at Viewbix, SciSparc, and other portfolio issuers

Multiple 20-F biographies (Jeffs' Brands 2025, Maris-Tech 2025) state: 'In April 2016, Mr. Weiss founded Amitay Weiss Management Ltd., an economic consulting company, and now serves as its chief executive officer.' Viewbix 10-K 2026 confirms the entity as 'Amitay Weiss Management Ltd.' holding indirect beneficial ownership. EDGAR assigns CIK 0001826620 to 'Weiss Amitay' as the reporting person across all Form 3/4 insider filings.

Tzemach Investment House Ltd. confirmed as private Israeli investment firm with Weiss as CEO/Director since July 2021; appears in exactly one EDGAR filing (ParaZero 20-F 2026)

ParaZero 20-F (accession 0001213900-26-034376, filed 2026-03-26) states: 'serving as Chief Executive Officer and a director of Tzemach Investment House Ltd., a private investment firm, since July 2021.' EDGAR full-text search for 'Tzemach Investment House' returns only 2 document hits, both within this single ParaZero 20-F. No LEI, OpenCorporates, or GLEIF records found.

Save Foods / N2OFF / Nexentis is the same entity (CIK 0001789192) — Weiss held Chairman role since 2020 through multiple name changes, currently Director

N2OFF (formerly Save Foods) underwent a series of corporate transformations: Save Foods Inc. (SVFD) → N2OFF Inc. (NITO) → Nexentis Technologies Inc. (NXTS), all under same CIK 0001789192. Weiss was Chairman of Save Foods since August 2020 per multiple 20-F biographies, and remains Director at Nexentis as of March 2026 HFIA Form 3.

Weiss resigned from Rail Vision (RVSN) board March 12, 2024 — his tenure was under 3 months; departure stated as not due to disagreement

Rail Vision 20-F (FY2024, accession 0001641172-25-001777) states Weiss was appointed to Rail Vision board on or before January 2024 (alongside Hila Kiron-Revach) and resigned March 12, 2024 'not due to any disagreement.' This confirms Rail Vision is no longer in the active Weiss portfolio.

Weiss chairs both SciSparc (acquiring company) and AutoMax Motors Ltd. (acquisition target) simultaneously during active merger process — no independent fairness opinion obtained

SciSparc 20-F (FY2024, accession 0001213900-25-035115) states: 'Mr. Amitay Weiss is also the Chairman of our board of directors and serves as the chairman of AutoMax.' The same document confirms no independent fairness opinion was obtained for the SciSparc-AutoMax merger. Weiss is identified as having interests that 'may present them with actual or potential conflicts of interest' regarding the merger.

Charging Robotics uplisted to Nasdaq in Dec 2025 with Weiss as Board Chairman and Audit Committee Chair; cohort member Tali Dinar joined as CFO (NIS 40,000/mo) immediately before uplisting

Charging Robotics (CHEV, CIK 0001459188) filed 8-A12B on 2025-12-22 (uplisting to Nasdaq). Prior S-1 registration filed 2025-10-24, amended through early 2026. Weiss served as Chairman and chairs both Audit Committee (as 'audit committee financial expert') and Compensation Committee throughout the uplisting process. Tali Dinar (also ParaZero Class II director) joined as CFO at NIS 40,000/month in September 2025.

Clearmind and SciSparc have a formal technology exploration agreement (March 2022); Weiss chairs both issuers and Oz Adler is SciSparc CEO/CFO while serving as Clearmind director — creating a three-way conflict nexus

Clearmind 20-F (Jan 2026) discloses related-party transaction: 'Oz Adler, one of our directors, serves as the Chief Executive Officer and Chief Financial Officer of SciSparc. Further to the agreement signed between us and SciSparc in March 2022, the purposes of which is to explore the technology cross-licensing...'. Weiss is Chairman of both Clearmind and SciSparc. The same director (Oz Adler) serves executive roles at SciSparc while on Clearmind's board.

All four Weiss HFIA Form 3 filings on 2026-03-18 were batch-processed through Toppan Merrill (0001213900 prefix); cohort co-director Alon Dayan also used same agent for late SciSparc Form 3

Weiss filed Form 3 at four issuers on the same date using EDGAR filer prefix 0001213900 (Toppan Merrill): ParaZero (0001213900-26-029463), SciSparc (0001213900-26-030644), Maris-Tech (0001213900-26-030812), Jeffs' Brands (0001213900-26-031244). A fifth Form 3 at SciSparc by Alon Dayan on 2026-03-23 (0001213900-26-032907) also used the same agent, indicating centralized compliance management for the cohort.

Weiss holds both President and Chairman titles at SciSparc (President since Oct 2025) — combining executive management and board governance roles at the cluster's flagship issuer

SciSparc 20-F (FY2025) indicates Weiss was elevated from Chairman to also hold President title as of October 2025, making him President and Chairman simultaneously. Previously served as CEO+Director Aug 2020-Jan 2022. This dual executive-governance role is unique within the cluster — at all other issuers Weiss serves as board chairman only, with separate executive management.

Weiss is confirmed executive officer at Gix Internet Ltd. (Xylo Technologies subsidiary); Viewbix chairman and CFO also serve at Gix Internet — creating a three-way connection between Viewbix, Gix Internet, and Xylo (the entity whose parent is SciSparc's Notes Investor)

Viewbix 10-K (FY2025, accession 0001493152-26-013205) states in related-party section: 'the executive officer of Gix Internet Ltd. is Mr. Amitay Weiss, a member of our board of directors, and the chief financial officer of Gix Internet Ltd is Mr. Amihay Hadad, our chief financial officer.' Also confirms 'Mr. Eliyahu Yoresh, the chairman of the board of directors, is also the chairman of the board of directors of Gix Internet Ltd.' Gix Internet is a subsidiary of Xylo Technologies (former Medigus, CIK 0001618500).

Weiss holds simultaneous board positions at 9 public Nasdaq/OTC micro-cap issuers, serving as Chairman at 5 and in audit/compensation committee chair roles at 3

Confirmed active board positions at: SciSparc (SPRC, President+Chairman), Clearmind Medicine (CMND, Chairman since 2019), ParaZero (PRZO, Chairman+Class I), Maris-Tech (MTEK, Chairman+Class II), Charging Robotics (CHEV, Board Chairman+Audit/Comp Committee Chair), Jeffs' Brands (JFBR, Director), Viewbix (VBIX, Director+Comp Committee Chair), N2OFF/Nexentis (NXTS, Director). Save Foods (SVFD, now NXTS) Chairman also confirmed from proxy filings. Total: 9 public issuers simultaneously.

Six repeat directors/officers confirmed across the Weiss cluster: Adler (×3), Revach (×3), Dinar (×2), Tzedef (×2), Dayan (×2), Baranes (×2) — constituting a professional governance cohort serving simultaneously across multiple issuers

Confirmed six recurring governance figures across Weiss-chaired issuers: Oz Adler (CEO/CFO SciSparc; director Clearmind, Jeffs' Brands), Tali Dinar (Class II director ParaZero; CFO Charging Robotics), Moshe Revach (director at ParaZero, SciSparc, Jeffs' Brands), Kineret Tzedef (audit committee chair Viewbix; planned post-uplist audit committee Charging Robotics), Alon Dayan (audit/comp committee Viewbix; director SciSparc — late Form 3 filed 2026-03-23), Yakov Baranes (subsidiary chairman Charging Robotics; market services to SciSparc-related issuers). All six appear in at least two of Weiss's issuers.